SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Pharmaceuticals’ arm divests stake in Rising Pharma Holdings, Inc

14 Dec 2021 Evaluate

Suven Pharmaceuticals’ wholly owned subsidiary company -- Suven Pharma, Inc., (SPI) has divested its stake in Rising Pharma Holdings, Inc., USA to Raisin Aggregator, L.P. USA one of the investment arm of H.I.G. Capital (H.I.G), a leading global alternative investment firm with over $45 billion of equity capital under management. H.I.G. has made a strategic equity investment into Rising Pharma Holdings and Casper Pharma (collectively ‘Rising Pharmaceuticals’), a leading provider of generic and specialty pharmaceuticals in the United States. As part of the structured deal Suven Pharma Inc., USA received cash and 7% stake in Raisin Aggregator, L.P. USA, the new company.

Suven Pharma, Inc, will become an investor in the new company as part of deal. H.I.G. is partnering with current management of Rising Pharmaceuticals, to continue the Company’s strong track record for growth and to support new initiatives such as M&A and new product launches etc.

Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

Cohance Lifesciences Share Price

391.60 28.35 (7.80%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×